|View printer-friendly version|
|Array BioPharma to Present at Leerink Swann Oncology Roundtable Conference|
|BOULDER, Colo., May 12, 2009 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Robert E. Conway, will speak at the Leerink Swann
Oncology Roundtable Conference on May 20 in New York City. The public is
welcome to participate in the conference through a webcast on the Array
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc.